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Summary 
A study about eosinophil-derived neurotoxin (EDN) as a bi-
omarker for eosinophilic esophagitis (EoE) has been reported in 
the February issue of Am J Gastroenterology 2010.
1 A diagnostic 
hallmark of EoE is the number of eosinophils infiltrated in the 
esophageal epithelium, but there seems to be no universal agree-
ment on either the number or the location of eosinophils required 
to diagnose EoE. Although the role of eosinophils in the patho-
physiology of EoE is not fully understood, eosinophils have a key 
role in eosinophil related gastrointestinal disease. Therefore eosi-
nophil granule protein and EDN released by eosinophils, and eo-
taxin-3 have been studied as other possible biomarkers of EoE. 
Blood, urine or tissue levels of eosinophil granule proteins and 
EDN are elevated in eosinophilic associated diseases.
2-6 Howev-
er, information regarding localization of EDN in the diseased tis-
sues has not been available.
The authors investigated tissue specimens from 10 adult 
EoE patients and 8 histologically normal controls. Using a poly-
cloncal rabbit antibody to EDN, sections from mid-esophageal 
biopsy specimens were stained for EDN by immunofluorescence. 
Cellular staining (infiltration of intact eosinophils) and extra-
cellular staining (deposition of released EDN) were scored in a 
blinded manner on an established 7-point scale.
In the results, esophageal biopsy specimens from normal 
controls showed no or few intact eosinophils and extracellular 
EDN depositions. In contrast, EDN staining was clearly ob-
served in specimens from all EoE patients. In some EoE pa-
tients, marked extracellular EDN deposition was observed de-
spite a relatively small numbers of intact eosinophils. And there 
was no correlation between the eosinophil infiltration and the ex-
tracellular EDN staining scores. 
They concluded that tissue eosinophil counts might under-
estimate how extensively eosinophils are involved, particularly in 
individuals with marked eosinophil degranulation. Evaluation of 
EDN in esophageal biopsy specimens was suggested as an useful 
mean to diagnose and manage patients with EoE.
Comment
EoE is a clinicopathologic disease characterized by an intense Eosinophil-Derived Neurotoxin and Eosinophilic Esophagitis
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eosinophilic infiltration in the esophageal epithelium, upper gas-
trointestinal symptoms (dysphagia, food impaction and heart-
burn etc) and lack of responsiveness to treatment with proton 
pump inhibitors.
7 There are some limitations in histologic diag-
nosis of EoE. Occasionally EoE is diagnosed as a patchy disease 
with variations in both numbers of eosinophils and histological 
findings. Because of the invasiveness and cost of endoscopy with 
insufficient tissue specimens to find eosinophils, and repeated 
procedures, we need noninvasive biomarkers of EoE which cor-
relate with presence and severity of disease, and response to 
therapy.
The complex pathophysiology of EoE provides several can-
didate biomarkers, for examples, eotaxin, chemokine receptor-3, 
IL-5, mast cell and eosinophil products.
8 Eosinophils contain cy-
toplasmic granules which is composed of major basic protein 
(MBP), eosinophil cationic protein, eosinophil peroxidase and 
EDN. High levels of such eosinophil granular proteins have 
been reported in serum and urine of patients with asthma, EoE or 
eosinophilic gastroenteritis.
2-6 In the recent EoE study, plasma 
EDN levels correlated with esophageal eosinophilic density and 
plasma EDN levels have been proposed as a noninvasive bio-
marker for diagnosing and monitoring EoE.
3 EDN levels in 
blood and stool significantly decreased at week 4 compared to 
baseline, after 4 weeks of corticosteroid therapy in a longitudinal 
study of children with EoE.
9
The authors had interests in the correlation of presence or 
distribution of EDN in esophageal tissues from EoE. They ex-
amined the distribution or location of EDN or MBP in the 
esophageal epithelial tissues by immunofluorescence. They found 
that 3 different patterns of EDN staining were observed in EoE 
patients: (1) primarily cell-associated, (2) a combination of cell 
associated and extracellular EDN deposition and (3) primarily 
extracellular EDN deposition. In addition, consistent with the 
patchy nature of EoE histology, heterogeneous EDN staining 
was seen not only in different biopsies taken from the same site, 
but also within the same biopsy specimen.
Besides the several limitations explained by the authors, I 
think that applying EDN immunofluorescence may not be a 
practical diagnostic method before confirming EoE, since we 
usually use the fresh tissues for the immunofluorescence method. 
Easier technique to stain EDN or MBP is expected to be devel-
oped in the future. Another potential biomarker of EoE is eotax-
in-3. Eotaxin mRNA is expressed constitutively in various parts 
of the gastrointestinal tract, and eotaxins may be involved in the 
selective regulation of eosinophil homing into the gastrointestinal 
tract. Eotaxin-3 gene, mRNA and protein were up-regulated in 
esophageal biopsies of children with EoE compared with normal 
controls.
4,10 Moreover, by means of correlation of biomarker lev-
els with mean esophageal eosinophilic density, blood eosinophils, 
EDN and eotaxin-3 are potential biomarkers of EoE.
3
In conclusion, we can learn 2 facts newly from this article: lo-
calization of EDN in esophageal tissue with EoE, reevaluation of 
extracellular EDN deposition in some EoE biopsies that con-
tained few eosinophils, and noninvasive biomarkers of EoE that 
correlate with disease presence, severity and response to therapy.
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